M NE 17 (Nisoldipine extended release 17 mg)
Pill imprint M NE 17 has been identified as Nisoldipine extended release 17 mg.
Nisoldipine is used in the treatment of raynaud's syndrome; high blood pressure; angina pectoris prophylaxis and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nisoldipine 17 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M NE 17 (Nisoldipine extended release 17 mg)
- 17 mg
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Yellow No. 6
Nisoldipine extended release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...